Steven Valiquette
Stock Analyst at Mizuho
(3.43)
# 927
Out of 4,959 analysts
112
Total ratings
55.36%
Success rate
3.03%
Average return
Main Sectors:
Stocks Rated by Steven Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NVST Envista Holdings | Maintains: Underperform | $15 → $18 | $21.45 | -16.08% | 2 | Aug 1, 2025 | |
| TDOC Teladoc Health | Initiates: Neutral | $10 | $7.66 | +30.55% | 1 | Jul 25, 2025 | |
| WAY Waystar Holding | Initiates: Outperform | $48 | $36.33 | +32.12% | 1 | Jun 30, 2025 | |
| VEEV Veeva Systems | Maintains: Outperform | $280 → $295 | $288.78 | +2.15% | 3 | Jun 2, 2025 | |
| DOCS Doximity | Maintains: Neutral | $65 → $60 | $67.57 | -11.20% | 3 | May 16, 2025 | |
| ALGN Align Technology | Maintains: Outperform | $250 → $245 | $149.42 | +63.97% | 11 | Apr 29, 2025 | |
| MCK McKesson | Maintains: Neutral | $630 → $690 | $687.34 | +0.39% | 3 | Apr 3, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $142 → $150 | $148.10 | +1.28% | 6 | Mar 31, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $21 → $18 | $14.61 | +23.25% | 7 | Mar 13, 2025 | |
| SOLV Solventum | Maintains: Neutral | $70 → $82 | $73.72 | +11.23% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $7 | $6.40 | +9.38% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $126 | $90.46 | +39.29% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $75 | $69.49 | +7.93% | 5 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $2.81 | +78.25% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $14 | $5.03 | +178.33% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $142 | $185.40 | -23.41% | 10 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 | $67.78 | -18.86% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $82 → $92 | $164.56 | -44.09% | 10 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $565 | $307.23 | +83.90% | 5 | Apr 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $71.32 | +40.21% | 1 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $14 | $4.35 | +221.84% | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $380 → $400 | $175.28 | +128.21% | 4 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $107 | $29.42 | +263.70% | 1 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $22 → $17 | $34.39 | -50.57% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $5 → $12 | $7.66 | +56.66% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $96 | $122.95 | -21.92% | 3 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $105 → $120 | $180.16 | -33.39% | 6 | Apr 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $127 | $405.37 | -68.67% | 1 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $327 → $358 | $299.70 | +19.45% | 3 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $78 → $60 | $12.12 | +395.25% | 3 | Apr 3, 2019 |
Envista Holdings
Aug 1, 2025
Maintains: Underperform
Price Target: $15 → $18
Current: $21.45
Upside: -16.08%
Teladoc Health
Jul 25, 2025
Initiates: Neutral
Price Target: $10
Current: $7.66
Upside: +30.55%
Waystar Holding
Jun 30, 2025
Initiates: Outperform
Price Target: $48
Current: $36.33
Upside: +32.12%
Veeva Systems
Jun 2, 2025
Maintains: Outperform
Price Target: $280 → $295
Current: $288.78
Upside: +2.15%
Doximity
May 16, 2025
Maintains: Neutral
Price Target: $65 → $60
Current: $67.57
Upside: -11.20%
Align Technology
Apr 29, 2025
Maintains: Outperform
Price Target: $250 → $245
Current: $149.42
Upside: +63.97%
McKesson
Apr 3, 2025
Maintains: Neutral
Price Target: $630 → $690
Current: $687.34
Upside: +0.39%
Cardinal Health
Mar 31, 2025
Maintains: Outperform
Price Target: $142 → $150
Current: $148.10
Upside: +1.28%
DENTSPLY SIRONA
Mar 13, 2025
Maintains: Neutral
Price Target: $21 → $18
Current: $14.61
Upside: +23.25%
Solventum
Mar 3, 2025
Maintains: Neutral
Price Target: $70 → $82
Current: $73.72
Upside: +11.23%
Dec 4, 2024
Initiates: Neutral
Price Target: $7
Current: $6.40
Upside: +9.38%
Dec 4, 2024
Initiates: Outperform
Price Target: $126
Current: $90.46
Upside: +39.29%
Dec 4, 2024
Initiates: Neutral
Price Target: $75
Current: $69.49
Upside: +7.93%
Dec 4, 2024
Initiates: Outperform
Price Target: $5
Current: $2.81
Upside: +78.25%
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $18 → $14
Current: $5.03
Upside: +178.33%
Sep 21, 2023
Maintains: Equal-Weight
Price Target: $142
Current: $185.40
Upside: -23.41%
Aug 4, 2023
Maintains: Overweight
Price Target: $55
Current: $67.78
Upside: -18.86%
Aug 2, 2023
Maintains: Overweight
Price Target: $82 → $92
Current: $164.56
Upside: -44.09%
Apr 14, 2023
Maintains: Overweight
Price Target: $565
Current: $307.23
Upside: +83.90%
Mar 30, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $71.32
Upside: +40.21%
Feb 27, 2023
Maintains: Overweight
Price Target: $17 → $14
Current: $4.35
Upside: +221.84%
Oct 28, 2022
Maintains: Overweight
Price Target: $380 → $400
Current: $175.28
Upside: +128.21%
Jul 28, 2022
Reinstates: Overweight
Price Target: $107
Current: $29.42
Upside: +263.70%
Apr 18, 2022
Downgrades: Equal-Weight
Price Target: $22 → $17
Current: $34.39
Upside: -50.57%
Jun 11, 2021
Upgrades: Overweight
Price Target: $5 → $12
Current: $7.66
Upside: +56.66%
Nov 23, 2020
Upgrades: Overweight
Price Target: $96
Current: $122.95
Upside: -21.92%
Apr 30, 2020
Reiterates: Neutral
Price Target: $105 → $120
Current: $180.16
Upside: -33.39%
Apr 22, 2020
Maintains: Overweight
Price Target: $117 → $127
Current: $405.37
Upside: -68.67%
Dec 6, 2019
Maintains: Overweight
Price Target: $327 → $358
Current: $299.70
Upside: +19.45%
Apr 3, 2019
Maintains: Equal-Weight
Price Target: $78 → $60
Current: $12.12
Upside: +395.25%